- Home
- TIL vs NAZ Comparison
TIL vs NAZ Comparison
Compare TIL & NAZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- NAZ
- Stock Information
- Founded
- TIL 2018
- NAZ 1992
- Country
- TIL United States
- NAZ United States
- Employees
- TIL N/A
- NAZ N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- NAZ Finance/Investors Services
- Sector
- TIL Health Care
- NAZ Finance
- Exchange
- TIL Nasdaq
- NAZ Nasdaq
- Market Cap
- TIL 170.7M
- NAZ 139.4M
- IPO Year
- TIL 2021
- NAZ N/A
- Fundamental
- Price
- TIL $21.17
- NAZ $11.73
- Analyst Decision
- TIL Buy
- NAZ
- Analyst Count
- TIL 4
- NAZ 0
- Target Price
- TIL $100.33
- NAZ N/A
- AVG Volume (30 Days)
- TIL 107.5K
- NAZ 18.3K
- Earning Date
- TIL 11-13-2024
- NAZ 01-01-0001
- Dividend Yield
- TIL N/A
- NAZ 3.69%
- EPS Growth
- TIL N/A
- NAZ N/A
- EPS
- TIL N/A
- NAZ N/A
- Revenue
- TIL N/A
- NAZ N/A
- Revenue This Year
- TIL N/A
- NAZ N/A
- Revenue Next Year
- TIL $2.65
- NAZ N/A
- P/E Ratio
- TIL N/A
- NAZ N/A
- Revenue Growth
- TIL N/A
- NAZ N/A
- 52 Week Low
- TIL $6.72
- NAZ $9.22
- 52 Week High
- TIL $92.00
- NAZ $11.37
- Technical
- Relative Strength Index (RSI)
- TIL 36.47
- NAZ 31.09
- Support Level
- TIL $20.57
- NAZ $12.18
- Resistance Level
- TIL $22.69
- NAZ $12.38
- Average True Range (ATR)
- TIL 2.72
- NAZ 0.11
- MACD
- TIL -0.23
- NAZ -0.08
- Stochastic Oscillator
- TIL 2.98
- NAZ 2.86
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About NAZ Nuveen Arizona Quality Municipal Income Fund
Nuveen Arizona Quality Municipal Income Fund is a closed-end management investment company. Its primary investment objective is to provide current income exempt from both regular federal income taxes and Arizona individual income taxes. The fund's secondary objective is to enhance the portfolio value relative to the Arizona municipal bond market through investments in tax-exempt Arizona Municipal Obligations that, in the opinion of the Fund's investment adviser, are underrated or undervalued or represent municipal market sectors that are undervalued.